News

Biologicals dominate Europe’s best sellers

Published on 2015/03/18

The landscape of blockbuster medicines in Europe has been changing over the last years from small molecule drugs to biologicals. Biologicals now dominate the top 10 list of best-selling medic...

3 views

Read more →

Influence of CETA on generics

Published on 2015/03/16

On 18 October 2013, the European Union (EU) and Canada reached a political agreement on the key elements for a Comprehensive Economic and Trade Agreement (CETA). However, CETA has been criticized fo...

1 views

Read more →

ECCO position statement on biosimilars

Published on 2015/03/12

The European Crohn’s and Colitis Organisation (ECCO) is a non-profit association with the aim of improving the care of patients with inflammatory bowel disease (IBD) in Europe. The association cur...

11 views

Read more →

Factors influencing use of generic asthma drugs in Morocco

Published on 2015/03/10

Despite the introduction of methods to promote the use of generics, use of generic anti-asthmatic drugs remains limited in Morocco. The Moroccan market therefore remains largely dominated by patent-...

4 views

Read more →

EMA criticized for change in data transparency plans

Published on 2015/03/06

New Legislation approved by the European Parliament on 2 April 2014 aims to increase transparency with respect to clinical trials by making the results publicly available. The Clinical Trials Regula...

5 views

Read more →

Factors supporting a sustainable European biosimilars market

Published on 2015/03/04

Factors that will support a sustainable biosimilars market in Europe include education, encouraging competition, publication of real-world evidence and transparent decision-making processes, accordi...

5 views

Read more →

Can the pursuit of biosimilar interchangeability go too far?

Published on 2015/03/02

The question of biosimilar interchangeability – whether or not a biosimilar can safely be switched with another biosimilar or with the originator product – is a thorny one. In fact, write Hans C...

1 views

Read more →

Europe–Japan cooperation on generics and biosimilars regulation

Published on 2015/02/26

Japanese and European generics groups have met to discuss increase regulatory cooperation between the two regions. The Japanese Generic Medicines Association (JGA), the Nippon Keidanren (Japanese I...

4 views

Read more →

Top 8 blockbuster biologicals 2013

Published on 2015/02/24

The top three best-selling drugs during 2013 were biologicals. All three best-sellers are indicated for the treatment of arthritis, and include Abbott’s Humira (adalimumab), Merck’s Remicade (in...

2 views

Read more →

Impact of price cuts on spending on hyperlipidaemic drugs in South Korea

Published on 2015/02/20

Rapidly increasing pharmaceutical expenditures have become a constant challenge to the sustainability of healthcare systems across countries including Korea. Policies for pharmaceuticals can ...

2 views

Read more →

Brazil speeds up approval process for generics and biologicals

Published on 2015/02/18

Brazil’s National Health Surveillance Agency [Agência Nacional de Vigilância Sanitária, ANVISA] announced on 3 June 2014 the publication of a new guideline for generics and biologicals aimed at...

8 views

Read more →

The global biologicals market

Published on 2015/02/16

Global spending on medicines is expected to reach the US$1 trillion threshold in 2014 and rise to US$1.2 trillion by 2017. This increase is mainly attributed to greater access to medicines by...

3 views

Read more →